Control of Cell Respiration and Apoptosis by Phosphorylation of Cytochrome c
通过细胞色素 c 磷酸化控制细胞呼吸和凋亡
基本信息
- 批准号:9236889
- 负责人:
- 金额:$ 36.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinity ChromatographyAmino AcidsAnimalsApoptosisApplications GrantsBacteriaBindingCandidate Disease GeneCattleCell DeathCell LineCell RespirationCellsCellular StressCessation of lifeCrystallographyCytoprotectionDataDiabetes MellitusDiseaseElectron TransportElectronsFunctional disorderGenerationsGlutamatesGoalsHeartIn VitroKidneyKnock-outKnockout MiceLaboratoriesLeadLeftLifeLiverMalignant NeoplasmsMapsMass Spectrum AnalysisMeasurementMediatingMembrane PotentialsMetabolicMethodsMitochondriaMitochondrial ProteinsModelingModificationMusNerve DegenerationNull LymphocytesOrganOxidative PhosphorylationOxygenPathologicPathway interactionsPharmacologyPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPlayPositioning AttributePost-Translational Protein ProcessingProcessProductionPropertyProtein DephosphorylationProteinsProtocols documentationRattusReactionReactive Oxygen SpeciesRegulationResearchRespirationRoleSignal PathwaySignal TransductionSignaling MoleculeStressTechniquesTestingTissuesTransgenic MiceTransgenic OrganismsTyrosineVariantWaterWorkX-Ray Crystallographyadenylate kinaseapoptotic protease-activating factor 1basecytochrome ccytochrome c oxidaseexperienceexperimental studygenetic approachin vivomitochondrial membranemutantnoveloverexpressionprevent
项目摘要
SUMMARY
Cytochrome c (Cytc) plays a central role in mitochondrial respiration and type 2
apoptosis. We have developed new protocols to purify mitochondrial proteins while
maintaining their physiological regulatory properties and posttranslational modifications,
and we discovered that Cytc is phosphorylated on distinct tyrosine residues in heart and
liver tissue. Recently, we have mapped two more phosphorylation sites on Cytc purified
from cow and rat kidneys, Thr28 and Ser47, which are the primary focus of this grant
application. Supported by strong preliminary data it is our overall hypothesis that Cytc
phosphorylation regulates the two main functions of Cytc, mitochondrial respiration and
apoptosis. Our long term goal is to understand the regulation of Cytc by cell signaling
pathways under normal and pathological conditions. As a first step towards our goal we
will test four specific hypotheses: 1) to test the hypothesis that kidney Cytc can be
phosphorylated on Thr28 and Ser47, and that these modifications affect the basic
properties of the molecule; 2) to test the hypothesis that Cytc Thr28 and Ser47
phosphorylation affects mitochondrial respiration and apoptosis; 3) to identify kinases
and phosphatases that control Cytc phosphorylation; and 4) to demonstrate the
physiological effect in mice. Phosphorylated Cytc will be isolated from cow and rat
kidneys and phosphomimetic mutant Cytc will be overexpressed and purified from
bacteria, followed by structural characterization using mass spectrometry, spectroscopic
methods, and protein crystallography (Aim 1). Phosphorylated and phosphomimetic
mutant Cytc will be subjected to a comprehensive set of functional analyses including in
vitro respiration and apoptosis measurements, and by in vivo studies with
phosphomimetic Cytc stably expressed in Cytc knockout cells (Aim 2). We will next lay
the ground work to explore the signaling pathways and identify kinases and
phosphatases that act on Cytc using affinity purification/mass spectrometry techniques
(Aim 3). Finally, we will reintroduce phosphomimetic and non-phosphorylatable mutant
Cytc into Cytc knockout mice to study the effect of Cytc modification and regulation at
the animal level (Aim 4). We expect that this research will reveal that Cytc, a protein that
makes life and death decisions, is subject to regulation by cell signaling, opening new
opportunities for the understanding of mitochondrial respiration and apoptosis, and to
control it in pathological conditions in which respiration and apoptosis are dysregulated.
概括
细胞色素 c (Cytc) 在线粒体呼吸和 2 型呼吸中发挥核心作用
细胞凋亡。我们开发了新的方案来纯化线粒体蛋白,同时
维持其生理调节特性和翻译后修饰,
我们发现 Cytc 在心脏和心脏中的不同酪氨酸残基上被磷酸化
肝组织。最近,我们在纯化的 Cytc 上绘制了另外两个磷酸化位点
来自牛和大鼠肾脏的 Thr28 和 Ser47,这是本次资助的主要重点
应用。有强有力的初步数据支持,我们的总体假设是 Cytc
磷酸化调节 Cytc 的两个主要功能:线粒体呼吸和
细胞凋亡。我们的长期目标是了解细胞信号传导对 Cytc 的调节
正常和病理条件下的途径。作为实现我们目标的第一步,我们
将检验四个具体假设:1)检验肾脏 Cytc 可以被
Thr28 和 Ser47 被磷酸化,这些修饰会影响基本的
分子的性质; 2) 检验 Cytc Thr28 和 Ser47 的假设
磷酸化影响线粒体呼吸和细胞凋亡; 3) 鉴定激酶
和控制 Cytc 磷酸化的磷酸酶; 4) 展示
对小鼠的生理作用。将从牛和大鼠中分离磷酸化的 Cytc
肾脏和拟磷突变体 Cytc 将从中过度表达和纯化
细菌,然后使用质谱、光谱进行结构表征
方法和蛋白质晶体学(目标 1)。磷酸化和拟磷化
突变体 Cytc 将接受一系列全面的功能分析,包括
体外呼吸和细胞凋亡测量,以及通过体内研究
拟磷化 Cytc 在 Cytc 敲除细胞中稳定表达(目标 2)。接下来我们将铺设
探索信号通路和识别激酶的基础工作
使用亲和纯化/质谱技术作用于 Cytc 的磷酸酶
(目标 3)。最后,我们将重新引入拟磷酸化和不可磷酸化的突变体
将 Cytc 转入 Cytc 敲除小鼠中,研究 Cytc 修饰和调节的效果
动物水平(目标 4)。我们预计这项研究将揭示 Cytc,一种蛋白质,
做出生死决定,受到细胞信号传导的调节,开启新的
了解线粒体呼吸和细胞凋亡的机会,并
在呼吸和细胞凋亡失调的病理条件下控制它。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAIK HUETTEMANN其他文献
MAIK HUETTEMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAIK HUETTEMANN', 18)}}的其他基金
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest
LUCID 的开发和测试:婴儿心脏骤停后脑损伤的治疗装置
- 批准号:
10515831 - 财政年份:2022
- 资助金额:
$ 36.74万 - 项目类别:
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest
LUCID 的开发和测试:婴儿心脏骤停后脑损伤的治疗装置
- 批准号:
10708811 - 财政年份:2022
- 资助金额:
$ 36.74万 - 项目类别:
Non-invasive mitochondrial modulation therapy for ischemic stroke
缺血性中风的非侵入性线粒体调节疗法
- 批准号:
10352458 - 财政年份:2021
- 资助金额:
$ 36.74万 - 项目类别:
Non-invasive mitochondrial modulation therapy for ischemic stroke
缺血性中风的非侵入性线粒体调节疗法
- 批准号:
10231915 - 财政年份:2021
- 资助金额:
$ 36.74万 - 项目类别:
Non-invasive mitochondrial modulation therapy for ischemic stroke
缺血性中风的非侵入性线粒体调节疗法
- 批准号:
10583532 - 财政年份:2021
- 资助金额:
$ 36.74万 - 项目类别:
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury
Infant NeuroLUX:一种治疗新生儿缺氧性脑损伤的新型非侵入性治疗装置
- 批准号:
10001121 - 财政年份:2019
- 资助金额:
$ 36.74万 - 项目类别:
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury
Infant NeuroLUX:一种治疗新生儿缺氧性脑损伤的新型非侵入性治疗装置
- 批准号:
10017347 - 财政年份:2019
- 资助金额:
$ 36.74万 - 项目类别:
Control of Cell Respiration and Apoptosis by Phosphorylation of Cytochrome c
通过细胞色素 c 磷酸化控制细胞呼吸和凋亡
- 批准号:
9982332 - 财政年份:2017
- 资助金额:
$ 36.74万 - 项目类别:
Limiting brain reperfusion injury by controlling mitochondrial function
通过控制线粒体功能限制脑再灌注损伤
- 批准号:
9149032 - 财政年份:2015
- 资助金额:
$ 36.74万 - 项目类别:
Regulation of Respiration and Apoptosis by Cytochrome c Phosphorylation.
细胞色素 c 磷酸化对呼吸和细胞凋亡的调节。
- 批准号:
8306157 - 财政年份:2010
- 资助金额:
$ 36.74万 - 项目类别:
相似国自然基金
Mpro蛋白靶向亲和层析定向挖掘白及属中药抗新冠肺炎活性芪类成分
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
原子水平一体化构建腺相关病毒亲和层析介质及分子设计基础
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于凝集素芯片与凝集素亲和层析技术的参芪扶正注射液联合 IFN-α对肝癌切除术后复发转移干预机制的糖蛋白组学研究
- 批准号:81803954
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
基于生物质谱和亲和层析策略的大肠杆菌O157: H7特异性抗体的靶蛋白及多肽抗原表位的鉴定与研究
- 批准号:31701680
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
治疗SLE复方中的抗炎物质分离及对狼疮活动干预机制的研究
- 批准号:81673857
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别:
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
量化血浆中的蛋白质确实使 1 型糖尿病患者的个性化医疗民主化
- 批准号:
10730284 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别:
Advancing Development of Novel Immunotherapy for Chemotherapy-induced Peripheral Neuropathy (CIPN)
推进化疗引起的周围神经病变 (CIPN) 的新型免疫疗法的发展
- 批准号:
10588384 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别:
Defining the molecular interactions required for flavivirus genome packaging and virus assembly
定义黄病毒基因组包装和病毒组装所需的分子相互作用
- 批准号:
10750591 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别:
Targeting methylglyoxal-induced diabetic neuropathic pain through the integrated stress response
通过综合应激反应针对甲基乙二醛诱发的糖尿病神经性疼痛
- 批准号:
10567294 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别: